Quentin Nevers
Jouy-sur-morin, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Optimization of the antiviral spectrum of cyclophilin inhibitors targeting respiratory viruses.
Journal: Antimicrobial agents and chemotherapy
Published: July 17, 2026
Inhibition of influenza virus replication by artificial proteins (αReps) targeting its RNA-polymerase.
Journal: Antiviral research
Published: September 30, 2025
Monomeric Structure of Influenza A Virus NEP/NS2 Obtained With an Artificial Protein Highlights Conformational Plasticity.
Journal: Journal of molecular biology
Published: September 12, 2025
Identification and characterization of a nonpeptidic cyclophilin ligand with antiviral activity against feline and porcine α-coronaviruses.
Journal: Veterinary research
Published: May 07, 2025
Rabies P protein inhibits TBK1 and interferes with innate immunity‑related condensates
Journal: Medecine sciences : M/S
Published: November 29, 2023
Genomic characterization of equine influenza A subtype H3N8 viruses by long read sequencing and functional analyses of the PB1-F2 virulence factor of A/equine/Paris/1/2018.
Journal: Veterinary research
Published: October 26, 2023
Antiviral activity of intracellular nanobodies targeting the influenza virus RNA-polymerase core.
Journal: PLoS pathogens
Published: August 30, 2023
Desloratadine, an FDA-approved cationic amphiphilic drug, inhibits SARS-CoV-2 infection in cell culture and primary human nasal epithelial cells by blocking viral entry.
Journal: Scientific reports
Published: January 12, 2022
Negri bodies and other virus membrane-less replication compartments.
Journal: Biochimica et biophysica acta. Molecular cell research
Published: July 01, 2020
Last Updated: 09/26/2026